Avidity Biosciences

+$0.13 (+0.58%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell RNA and other stocks, options, and ETFs commission-free!

About RNA

Avidity Biosciences, Inc. engages in the development of a new class of oligonucleotide-based therapies called Antibody Oligonucleotide Conjugates (AOC). It utilizes its AOC platform to design, engineer, and develop therapeutics that combine the tissue selectivity of monoclonal antibodies and the precision of oligonucleotide-based therapies in order to access previously undruggable tissue and cell types and more effectively target underlying genetic drivers of diseases.

CEO
Sarah Boyce
Employees
82
Headquarters
La Jolla, California
Founded
2012

RNA Key Statistics

Market Cap
833.32M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
223.35K
High Today
$22.82
Low Today
$21.91
Open Price
$22.41
Volume
119.06K
52 Week High
$37.46
52 Week Low
$19.12

RNA Earnings

-$1.23
-$0.82
-$0.41
$0.00
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 12, After Hours

You May Also Like

MTB
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure